Vesicular systems in ocular drug delivery: an overview

被引:309
作者
Kaur, IP [1 ]
Garg, A [1 ]
Singla, AK [1 ]
Aggarwal, D [1 ]
机构
[1] Panjab Univ, Inst Pharmaceut Sci, Chandigarh 160014, India
关键词
niosomes; liposomes; vesicular drug delivery; ophthalmics;
D O I
10.1016/j.ijpharm.2003.09.016
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The main aim of pharmacotherapeutics is the attainment of effective drug concentration at the intended site of action for a sufficient period of time to elicit a response. Poor bioavailability of drugs from ocular dosage form is mainly due to the tear production, non-productive absorption, transient residence time, and impermeability of corneal epithelium. Though the topical and localized application are still an acceptable and preferred way to achieve therapeutic level of drugs used to treat ocular disorders but the primitive ophthalmic solution, suspension, and ointment dosage form are no longer sufficient to combat various ocular diseases. This article reviews the constraints with conventional ocular therapy and explores various novel approaches, in general, to improve ocular bioavailability of the drugs, advantages of vesicular approach over these and the future challenges to render the vesicular system more effective. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 14
页数:14
相关论文
共 99 条
[21]  
DELAVAL W, 1992, FARMACJA POLSKA, V48, P359
[22]  
Desai SD, 1994, ENCY PHARM TECHNOLOG, V11, P43
[23]  
DHARMA SK, 1986, ACTA OPHTHALMOL, V64, P298
[24]   Preparation and evaluation of acetazolamide liposomes as an ocular delivery system [J].
El-Gazayerly, ON ;
Hikal, AH .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 158 (02) :121-127
[25]   COMPARISON OF PARTICLE-SIZE AND ENCAPSULATION PARAMETERS OF 3 LIPOSOMAL PREPARATIONS [J].
ELORZA, B ;
ELORZA, MA ;
SAINZ, MC ;
CHANTRES, JR .
JOURNAL OF MICROENCAPSULATION, 1993, 10 (02) :237-248
[26]   Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention [J].
Felt, O ;
Furrer, P ;
Mayer, JM ;
Plazonnet, B ;
Buri, P ;
Gurny, R .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 180 (02) :185-193
[27]  
FELT O, 1996, ENCY CONTROLLED DRUG, P605
[28]   TOPICALLY APPLIED PILOCARPINE - HUMAN PUPILLARY RESPONSE AS A FUNCTION OF DROP SIZE [J].
FILE, RR ;
PATTON, TF .
ARCHIVES OF OPHTHALMOLOGY, 1980, 98 (01) :112-115
[29]   A GAMMA-SCINTIGRAPHIC EVALUATION OF THE PRECORNEAL RESIDENCE OF LIPOSOMAL FORMULATIONS IN THE RABBIT [J].
FITZGERALD, P ;
HADGRAFT, J ;
WILSON, CG .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1987, 39 (06) :487-490
[30]   Characterization and in-vivo ocular absorption of liposome-encapsulated acyclovir [J].
Fresta, M ;
Panico, AM ;
Bucolo, C ;
Giannavola, C ;
Puglisi, G .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1999, 51 (05) :565-576